Iidaka Takeshi | Drug Safety Research And Development Pfizer Global Research And Development Nagoya Laboratories. Pfi
スポンサーリンク
概要
- 同名の論文著者
- Drug Safety Research And Development Pfizer Global Research And Development Nagoya Laboratories. Pfiの論文著者
関連著者
-
Iidaka Takeshi
ファイザー 中央研究所
-
Iidaka Takeshi
Drug Safety Research And Development Pfizer Global Research And Development Nagoya Laboratories. Pfi
-
Iidaka Takeshi
ファイザー製薬中央研究所 安全性研究統括部
-
Iidaka Takeshi
Drug Safety Research And Development Nagoya Laboratories Pfizer Global Research And Development Pfiz
-
Iidaka Takeshi
ファイザー製薬中央研究所 安全性研究
-
Kurata Masaaki
ファイザー製薬中央研究所 安全性研究統括部
-
Kurata Masaaki
Drug Safety Research And Development Nagoya Laboratories Pfizer Global Research And Development Pfiz
-
Kurata Masaaki
Worldwide Safety Sciences Pfizer Global Research And Development Nagoya Laboratories Pfizer Inc.
-
YAMASAKI Naoko
Worldwide Safety Sciences, Pfizer Global Research & Development, Nagoya Laboratories, Pfizer Inc.
-
Yamasaki Naoko
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
IIDAKA Takeshi
Worldwide Safety Sciences, Nagoya Laboratories, Pfizer Global Research and Development, Pfizer Japan
-
Iidaka Takeshi
Worldwide Safety Sciences Pgrd Nagoya Laboratories Pfizer Inc.
-
SASAYAMA Yukiko
Worldwide Safety Sciences, Pfizer Global Research & Development, Nagoya Laboratories, Pfizer Inc.
-
Sasayama Yukiko
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Hamada Y.
Drug Safety Research And Development Pfizer Global Research And Development Nagoya Laboratories. Pfi
-
IIDAKA TAKESHI
Drug Safety Evaluation, Nagoya Laboratories, Pfizer Global Research and Development
-
HAMADA Yoshimasa
Worldwide Safety Sciences, Pfizer Global Research and Development, Nagoya Laboratories, Pfizer Inc.
-
Kurata Masaaki
Drug Safety Research And Development Nagoya Laboratories Pfizer Global Research And Development Pfiz
-
Shirai Norimitsu
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Hamada Yoshimasa
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Japan Inc.
-
Sato Yasushi
Drug Safety Research And Development Nagoya Laboratories Pfizer Global Research And Development Pfiz
-
Hamada Yoshimasa
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Inc.
-
SHIRAI Norimitsu
Worldwide Safety Sciences, Nagoya Laboratories, Pfizer Global Research and Development, Pfizer Japan
-
HORII IKUO
Drug Safety Evaluation, Nagoya Laboratories, Pfizer Global Research and Development
-
Sakimura Masanori
worldwide safety sciences
-
Horii Ikuo
Showa Univ. (department Of Biochemical Toxicology School Of Pharmaceutical Sciences)
-
Horii I
Drug Safety Research And Development Pfizer Global Research And Development Nagoya Laboratories. Pfi
-
Horii Ikuo
Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
HAMADA Yoshimasa
Drug Safety Research and Development, Nagoya Laboratories, Pfizer Japan Inc.
-
SATO Yasushi
Drug Safety Research & Development, Pfizer Global Research & Development, Nagoya Laboratories
-
FUKUSHIMA Tamio
Worldwide Safety Sciences, Global Research & Development, Nagoya Laboratories, Pfizer Inc.
-
Sakimura Masanori
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
NII Aisuke
Drug Safety Research and Development ; Global Research and Development, Nagoya Laboratories, Pfizer
-
Fukushima Tamio
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
TASHIRO Toshifumi
Drug Safety Research and Development, Nagoya Laboratories, Pfizer Global Research and Development, P
-
NAGAKUI Yuko
Drug Safety Research and Development, Nagoya Laboratories, Pfizer Global Research and Development, P
-
NAKAMURA Takaaki
Drug Safety Research and Development, Nagoya Laboratories, Pfizer Global Research and Development, P
-
TSUJIMURA Yumiko
Pfizer Pharmaceutical Inc., Drug Safety Evaluation
-
KURATA Masaaki
Pfizer Pharmaceutical Inc., Drug Safety Evaluation
-
IIDAKA Takeshi
Pfizer Pharmaceutical Inc., Drug Safety Evaluation
-
TAKAHASHI Mamoru
Pfizer Pharmaceutical Inc., Drug Safety Evaluation
-
SHIMOYA Machiko
Pfizer Pharmaceutical Inc., Drug Safety Evaluation
-
KATO Mariko
Pfizer Pharmaceutical Inc., Drug Safety Evaluation
-
FURUTA Chikako
Pfizer Pharmaceutical Inc., Drug Safety Evaluation
-
SHIRAI Norimitsu
Pfizer Pharmaceutical Inc., Drug Safety Evaluation
-
SATO Yasushi
Pfizer Pharmaceutical Inc., Drug Safety Evaluation
-
MAKO Tomomi
Worldwide Safety Sciences, Global Research & Development Nagoya Laboratories, Pfizer Japan Inc.
-
Horii Ikuo
Worldwide Safety Sciences Pgrd Nagoya Laboratories Pfizer Inc.
-
Mako Tomomi
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Japan Inc.
-
Nagakui Yuko
Drug Safety Research And Development Nagoya Laboratories Pfizer Global Research And Development Pfiz
-
Tashiro Toshifumi
Drug Safety Research And Development Nagoya Laboratories Pfizer Global Research And Development Pfiz
-
Nakamura Takaaki
Drug Safety Research And Development Nagoya Laboratories Pfizer Global Research And Development Pfiz
-
IIDAKA Tadashi
Worldwide Safety Sciences, Pfizer Global Research & Development, Nagoya Laboratories, Pfizer Inc.
-
Nii Aisuke
Drug Safety Research And Development Nagoya Laboratories Pfizer Global Research And Development Pfiz
-
Furuta Chikako
Pfizer Pharmaceutical Inc. Drug Safety Evaluation
-
Horii Ikuo
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Shimoya Machiko
Pfizer Pharmaceutical Inc. Drug Safety Evaluation
-
Nii Aisuke
Drug Safety Research & Development Nagoya Laboratories Pfizer Global Research And Development
-
Tsujimura Yumiko
Pfizer Pharmaceutical Inc. Drug Safety Evaluation
-
Horii Ikuo
Drug Safety Evaluation Pfizer Global Research And Development
-
Kato Mariko
Pfizer Pharmaceutical Inc. Drug Safety Evaluation
-
Horii Ikuo
Drug Safety Evaluation Global Research & Development Pfizer Inc.
-
Horii Ikuo
Biochemical Toxicology School Of Pharmaceutical Sciences Showa University
-
Takahashi Mamoru
Pfizer Pharmaceutical Inc. Drug Safety Evaluation
-
Hamada Yoshimasa
Drug Safety Research And Development Nagoya Laboratories Pfizer Japan Inc.
-
Sato Yasushi
Drug Safety And Pharmacokinetics Laboratories Taisho Pharmaceutical Co. Ltd.
-
Tashiro Toshifumi
Drug Safety & Disposition Research Laboratories, Eisai Co., Ltd.
著作論文
- Markers for detecting myocardial damage in rats : From a view of clinical pathology(Blood, Biomarker, Proceedings of the 32nd Annual Meeting)
- Erythroderma and Epidermal Necrosis Induced by a Type of Proton Pump Inhibitor in Beagle Dogs
- P-61 Comparison of general toxicological parameters between Crj : CD (SD) IGS and Slc : SD rats(Proceedings of the 27th Annual Meeting)
- SIMULTANEOUS MEASUREMENT OF NUCLEATED CELL COUNTS AND CELLULAR DIFFERENTIALS IN RAT BONE MARROW EXAMINATION USING FLOW CYTOMETER
- Battery of Tests for Profiling Abnormalities of Vitamin K-Dependent Coagulation Factors in Drug-Toxicity Studies in Rats
- P8-42 Technical examination for repeated blood collection and hematological tests in mice(BLOOD/TOXICOKINETICS/OTHERS-2)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- P8-41 Simple methods for evaluating abnormality in vitamin K-dependent coagulation factors in rats(BLOOD/TOXICOKINETICS/OTHERS-2)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)